Muralidhar Bali is a director of Reneo Pharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
SPRUCE BIOSCIENCES, INC.
24 May 24
4
Reneo Pharmaceuticals, Inc.
8 Jun 23
4
SPRUCE BIOSCIENCES, INC.
26 May 23
4
EXICURE, INC.
15 Jun 22
4
Reneo Pharmaceuticals, Inc.
3 Jun 22
4
SPRUCE BIOSCIENCES, INC.
27 May 22
4
EXICURE, INC.
19 May 22
4
Reneo Pharmaceuticals, Inc.
15 Jul 21
4
Reneo Pharmaceuticals, Inc.
25 Jun 21
4
Reneo Pharmaceuticals, Inc.
23 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 May 24 | SPRB Spruce Biosciences | Stock Option Common Stock | Grant | Acquire A | No | No | 0.7511 | 30,000 | 22.53 k | 30,000 |
6 Jun 23 | RPHM Reneo Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 9.01 | 17,500 | 157.68 k | 17,500 |
25 May 23 | SPRB Spruce Biosciences | Stock Option Common Stock | Grant | Acquire A | No | No | 2.26 | 30,000 | 67.80 k | 30,000 |